TickerFacts.

Intelligent Bio Solutions Inc. (INBS): Capital Expenditures

Annual figures by period end, from SEC filings.

$125.7K
Year ended 2026-06-30
$231.8K2024-06-30: $221.4K2025-06-30: $231.8K2026-06-30: $125.7K$125.7K
2024-06-30 Capital Expenditures (USD) 2026-06-30
Period endedCapital ExpendituresChange YoYSource filing
2026-06-30$125.7K-45.8%2026-08-19, From 2025-07-01
2025-06-30$231.8K+4.7%2026-08-19, From 2024-07-01
2024-06-30$221.4Kn/a2025-08-15, From 2023-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Intelligent Bio Solutions Inc. (INBS)2026-06-30$125.7K-45.8%
Tenon Medical, Inc. (TNON)2025-12-31$273.0K+46.8%
Lucid Diagnostics Inc. (LUCD)2025-12-31$197.0K-33.4%
Cerenome, Inc. (CNSY)2025-12-31$67.0K-54.1%
IceCure Medical Ltd. (ICCM)2025-12-31$36.0K-49.3%
Nuo Therapeutics, Inc. (AURX)2025-12-31$274.8K+77.3%
INVO Fertility, Inc. (IVF)2025-12-31$43.4K-76.4%
Beyond Air, Inc. (XAIR)2026-03-31$1.02M-82.6%
Femasys Inc (FEMY)2025-12-31$525.0K-31.1%

Compare INBS, TNON, LUCD, CNSY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗